Actively Recruiting
Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study
Led by Reuth Rehabilitation Hospital · Updated on 2025-09-11
8
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
Sponsors
R
Reuth Rehabilitation Hospital
Lead Sponsor
T
Tel Aviv University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate whether a culturally adapted group-based emotional therapy named "Emotional Awareness and Expression Therapy" can help reduce chronic pain and improve emotional well-being in Israeli adults who suffer from chronic musculoskeletal pain and are treated with medical cannabis. Researchers will compare patients who receive the emotional therapy along with their usual care to patients who receive usual care only, to see if the therapy leads to better outcomes in pain, mental health, and daily functioning. Participants will attend a weekly 1.5-hour group therapy session for 8 weeks; Take part in group discussions and emotional processing exercises; Complete questionnaires about pain levels, mood, sleep, and quality of life; Continue their usual medical treatment as prescribed by their doctors.
CONDITIONS
Official Title
Culturally Adapted EAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with chronic musculoskeletal pain lasting at least three months, including widespread pain or fibromyalgia
- Currently treated with medical cannabis
- Physically and mentally able to participate in group discussions
- Interested in exploring emotional factors related to their symptoms
- Signed informed consent form
You will not qualify if you...
- Diagnosed with hip/knee osteoarthritis, radiculopathy, tunnel syndromes confirmed by electromyography, autoimmune diseases that cause pain (such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, systemic lupus, sickle cell disease), cancer, or chronic infections causing pain
- Severe mental illness or psychiatric disorders such as schizophrenia, bipolar I disorder, multiple personality disorder, or dissociative identity disorder not controlled by medication
- Active risk of suicide or violence in the past year, or active severe alcohol or substance use disorder
- Unable to read or speak Hebrew fluently
- Currently participating in another clinical study or program involving psychological or behavioral interventions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Reuth Rehabilitation Hospital
Tel Aviv, Israel, 6772830
Actively Recruiting
Research Team
P
Pnina Marom, M.P.H.; Ph.D. Student
CONTACT
S
Shahar Lev-Ari, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here